CEFTIOCYL DIN 02417677
Status: Cancelled Post Market
Holder: VETOQUINOL N A INC
Molecule: CEFTIOFUR (CEFTIOFUR HYDROCHLORIDE)
Health Canada record
| Active ingredient(s) | CEFTIOFUR (CEFTIOFUR HYDROCHLORIDE) 50 MG |
|---|---|
| Dosage form | Suspension |
| Route | Intramuscular; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 13-May-2014 |
| Current status date | 02-Jun-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Vetoquinol N A Inc. — licence 100448, currently licensed, last inspection rating C (2025-10-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEFTIOFUR (CEFTIOFUR HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02458861 | CEVAXEL RTU | CEVA ANIMAL HEALTH INC | Suspension | CEFTIOFUR (CEFTIOFUR HYDROCHLORIDE) 50 MG | Marketed |
| 02443260 | EFICUR | LABORATORIOS HIPRA S.A. | Suspension | CEFTIOFUR (CEFTIOFUR HYDROCHLORIDE) 50 MG | Marketed |
| 02317214 | EXCENEL RTU EZ | ZOETIS CANADA INC | Suspension | CEFTIOFUR (CEFTIOFUR HYDROCHLORIDE) 50 MG | Marketed |
| 02312654 | SPECTRAMAST DC | ZOETIS CANADA INC | Suspension | CEFTIOFUR (CEFTIOFUR HYDROCHLORIDE) 500 MG | Marketed |
| 02298325 | SPECTRAMAST LC | ZOETIS CANADA INC | Suspension | CEFTIOFUR (CEFTIOFUR HYDROCHLORIDE) 125 MG | Marketed |
| 02239274 | EXCENEL RTU | ZOETIS CANADA INC | Suspension | CEFTIOFUR (CEFTIOFUR HYDROCHLORIDE) 50 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25029 | 2021-01-19 | Supplement to an Abbreviated New Drug Submission (SANDS) | MANUFACTURING CHANGES FOR DRUG PRODUCT |
| 14983 | 2013-12-04 | Abbreviated New Drug Submission (ANDS) |